• PRAZOSIN CHEMBL2 FDA Approved

    Alternate Names:

    Prazosin
    CP-12299
    C767
    SPBIO_001297
    BPBIO1_001006
    KBIO2_005512
    PRAZOSIN HCL
    BIO2_000358
    QUINAZOLINE, 4-AMINO-6,7-DIMETHOXY-2-(4-(2-FUROYL)PIPERAZIN-1-YL)-
    BRD-K49111258-001-02-8
    NCGC00024324-02
    HSDB 3298
    BIO2_000838
    HMS1362D17
    PRAZOSIN (INN)
    EINECS 242-885-8
    LENTOPRES
    SMP1_000063
    SPECTRUM3_000551
    KBIO2_002944
    SPECTRUM_000822
    2-(4-(2-FUROYL)PIPERAZIN-1-YL)-4-AMINO-6,7-DIMETHOXYQUINAZOLINE
    DAP000300
    PRAZOSINE [INN-FRENCH]
    9572
    KBIOGR_000965
    KBIO3_000732
    TNP00312
    LS-140002
    PRESTWICK2_000947
    CHEBI:8364
    NCGC00024324-04
    BRD-K49111258-003-05-7
    NCGC00016740-02
    19216-56-9
    HMS1792D17
    L000666
    IDI1_000375
    OPREA1_314778
    BSPBIO_002221
    ZINC00601304
    CID4893
    PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-FUROYL)- (8CI)
    DIVK1C_000375
    UNII-XM03YJ541D
    KBIO1_000375
    1-(3-AMINO-6,7-DIMETHOXY-2- QUINAZOLINYL)-4-(2-FURANYL-CARBONYL)PIPERAZINE HYDROCHLORIDE
    BCBCMAP01_000227
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-FURANYLCARBONYL) PIPERAZINE
    KBIO3_001721
    C07368
    IDI1_002113
    BRN 0768345
    NCGC00016740-14
    PRAZOSIN [INN:BAN]
    PRAZOSINA
    NINDS_000375
    CAS-19237-84-4
    HMS2089G09
    NCGC00024324-07
    DB00457
    AB00053528
    PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-FURANYLCARBONYL)- (9CI)
    SPECTRUM4_000483
    2-[4-(2-FUROYL)PIPERAZIN-1-YL]-6,7-DIMETHOXYQUINAZOLIN-4-AMINE
    NCGC00024324-06
    KBIO3_000731
    PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-FURANYLCARBONYL)-
    [3H]-PRAZOSIN
    KBIO2_000376
    KBIO2_003870
    4893
    D08411
    PRAZOCIN
    BIO1_001343
    KBIOGR_000376
    PRAZOSINUM
    SPECTRUM5_001365
    BSPBIO_000914
    NCGC00024324-05
    STK301545
    KBIOSS_001302
    KBIO2_006438
    ST075549
    NCGC00016740-01
    BIO1_000365
    PRAZOSINA [INN-SPANISH]
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-FURANYLCARBONYL)PIPERAZINE
    KBIOSS_000376
    BSPBIO_001036
    MOLPORT-000-891-036
    PRESTWICK1_000947
    JUSTAC
    PRESTWICK0_000947
    SPECTRUM2_001289
    FURAZOSIN
    TL8001573
    MINIPRESS (TN)
    PRAZOSINUM [INN-LATIN]
    4-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)PIPERAZINYL 2-FURYL KETONE
    NCGC00024324-08
    PRESTWICK3_000947
    BIO1_000854
    AC1L1J6T
    NCI60_002417
    5-25-13-00365 (BEILSTEIN HANDBOOK REFERENCE)
    AKOS000310009
    C19H21N5O4
    HMS1990D17
    [4-(4-AMINO-6,7-DIMETHOXY-QUINAZOLIN-2-YL)PIPERAZIN-1-YL]-(2-FURYL)METHANONE
    PRAZOSINE
    SPBIO_003073
    NCGC00016740-03
    NCGC00024324-09
    KBIO2_001302
    PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-FUROYL)-
    TOCRIS-0623
    DSSTOX_GSID_49082
    DSSTOX_RID_83272
    DSSTOX_CID_29008
    NCGC00016740-13
    IENZQIKPVFGBNW-UHFFFAOYSA-N
    MINIPRESS XL
    MINIPRESS
    XRA
    PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY- 2-QUINAZOLINYL)-4-(2-FURANYLCARBONYL)-
    2-{4-[(FURAN-2-YL)CARBONYL]PIPERAZIN-1-YL}-6,7-DIMETHOXYQUINAZOLIN-4-AMINE
    1-(3-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-FURANYL-CARBONYL)PIPERAZINE HYDROCHLORIDE
    [4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL](2-FURYL)METHANONE
    2-[4-(FURAN-2-YLCARBONYL)PIPERAZIN-1-YL]-6,7-DIMETHOXYQUINAZOLIN-4-AMINE
    6,7-DIMETHOXY-4-AMINO-2-[4-(2-FUROYL)PIPERAZIN-1-YL]QUINAZOLINE
    2-[4-(2-FUROYL)-1-PIPERAZINYL]-6,7-DIMETHOXY-4-QUINAZOLINAMINE #
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)4-(2-FUROYL)PIPERAZINE
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-FUROYL)PIPERAZINE
    3B2-1870
    AB00053528-19
    ST24038261
    FT-0630457
    KB-207710
    SMR001550197
    HE321891
    HE288937
    H961
    DR002181
    AN-18022
    AN-15618
    AK116466
    NCGC00024324-10
    NCGC00016740-19
    NCGC00016740-18
    NCGC00016740-15
    NCGC00016740-12
    NCGC00016740-11
    NCGC00016740-10
    NCGC00016740-09
    NCGC00016740-08
    NCGC00016740-07
    NCGC00016740-06
    NCGC00016740-05
    NCGC00016740-04
    MCULE-8104643269
    CS-2088
    AF-0052
    TOX21_113646_1
    ZINC95616601
    SBB032268
    BBL028799
    TOX21_113646
    HY-B0193
    HMS3403D17
    PRAZOSIN, PRAZOSIN HYDROCHLORIDE
    CTK7A0338
    BDBM29568
    XM03YJ541D
    GTPL5385
    MLS006011888
    GTPL503
    SCHEMBL26524
    [3H]-PRATSIOL
    [3H]-MINIPRESS
    [3H]-FURAZOSIN
    [3H]PRAZOSIN
    2-[4-(2-FUROYL)PIPERAZIN-1-YL]-4-AMINO-6,7-DIMETHOXYQUINAZOLINE
    PRESSIN
    MINIPRESSREG
    HYPOVASEREG
    CAS-19216-56-9
    W-107722
    2-[4-(FURAN-2-CARBONYL)PIPERAZIN-1-YL]-6,7-DIMETHOXYQUINAZOLIN-4-AMINE
    178101593
    CHORIOMAMMOTROPIN
    CSH2
    CSH1
    [4-(4-AZANYL-6,7-DIMETHOXY-QUINAZOLIN-3-IUM-2-YL)PIPERAZIN-1-YL]-(FURAN-2-YL)METHANONE
    [4-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-3-IUM-2-YL)PIPERAZIN-1-YL]-(FURAN-2-YL)METHANONE
    [4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLIN-3-IUMYL)-1-PIPERAZINYL]-(2-FURANYL)METHANONE
    A813563
    AC1O2ICS
    6200102
    135650849
    503

    Drug Info:

    FDA Approval 1976
    Drug Class small molecule
    Drug Indications antispasmodics
    Drug Indications Antihypertensive Agents
    Year of Approval 1976
    Drug Class antihypertensive agents
    Name of the Ligand Species (if a Peptide) Human
    Drug Class antispasmodics
    (4 More Sources)